HRP20130941T1 - Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena - Google Patents
Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena Download PDFInfo
- Publication number
- HRP20130941T1 HRP20130941T1 HRP20130941AT HRP20130941T HRP20130941T1 HR P20130941 T1 HRP20130941 T1 HR P20130941T1 HR P20130941A T HRP20130941A T HR P20130941AT HR P20130941 T HRP20130941 T HR P20130941T HR P20130941 T1 HRP20130941 T1 HR P20130941T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- scale
- ray diffraction
- salt according
- triazatetracyclo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22560909P | 2009-07-15 | 2009-07-15 | |
| PCT/SG2010/000265 WO2011008172A1 (en) | 2009-07-15 | 2010-07-14 | 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130941T1 true HRP20130941T1 (hr) | 2013-11-08 |
Family
ID=42790728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130941AT HRP20130941T1 (hr) | 2009-07-15 | 2010-07-14 | Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9062074B2 (enExample) |
| EP (1) | EP2454266B1 (enExample) |
| JP (2) | JP6013911B2 (enExample) |
| CN (1) | CN102762577B (enExample) |
| AR (2) | AR077483A1 (enExample) |
| BR (1) | BR112012000750B1 (enExample) |
| CA (1) | CA2768210C (enExample) |
| DK (1) | DK2454266T3 (enExample) |
| ES (1) | ES2429525T3 (enExample) |
| HR (1) | HRP20130941T1 (enExample) |
| MX (1) | MX2012000680A (enExample) |
| PL (1) | PL2454266T3 (enExample) |
| PT (1) | PT2454266E (enExample) |
| RU (1) | RU2543721C2 (enExample) |
| SI (1) | SI2454266T1 (enExample) |
| SM (1) | SMT201300112B (enExample) |
| TW (1) | TWI537276B (enExample) |
| WO (1) | WO2011008172A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1246653A1 (zh) | 2014-11-17 | 2018-09-14 | Context Biopharma Inc. | 奥那司酮延长释放组合物和方法 |
| US10308676B2 (en) | 2015-09-25 | 2019-06-04 | Context Biopharma Inc. | Methods of making onapristone intermediates |
| EP3389632A4 (en) | 2015-12-15 | 2019-11-06 | Context Biopharma Inc. | AMORPHIC ONAPRISTON COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
| US7151096B2 (en) | 2003-03-05 | 2006-12-19 | Irm Llc | Cyclic compounds and compositions as protein kinase inhibitors |
| ES2506040T3 (es) * | 2005-11-16 | 2014-10-13 | Cti Biopharma Corp. | Derivados de pirimidina ligados a oxígeno |
-
2010
- 2010-07-14 US US13/384,139 patent/US9062074B2/en active Active
- 2010-07-14 BR BR112012000750-5A patent/BR112012000750B1/pt active IP Right Grant
- 2010-07-14 CA CA2768210A patent/CA2768210C/en active Active
- 2010-07-14 RU RU2012105044/04A patent/RU2543721C2/ru active
- 2010-07-14 MX MX2012000680A patent/MX2012000680A/es active IP Right Grant
- 2010-07-14 EP EP10737645.1A patent/EP2454266B1/en active Active
- 2010-07-14 PT PT107376451T patent/PT2454266E/pt unknown
- 2010-07-14 DK DK10737645.1T patent/DK2454266T3/da active
- 2010-07-14 CN CN201080032627.5A patent/CN102762577B/zh active Active
- 2010-07-14 HR HRP20130941AT patent/HRP20130941T1/hr unknown
- 2010-07-14 WO PCT/SG2010/000265 patent/WO2011008172A1/en not_active Ceased
- 2010-07-14 PL PL10737645T patent/PL2454266T3/pl unknown
- 2010-07-14 SI SI201030347T patent/SI2454266T1/sl unknown
- 2010-07-14 JP JP2012520571A patent/JP6013911B2/ja active Active
- 2010-07-14 ES ES10737645T patent/ES2429525T3/es active Active
- 2010-07-15 TW TW099123331A patent/TWI537276B/zh active
- 2010-07-15 AR ARP100102594A patent/AR077483A1/es not_active Application Discontinuation
-
2013
- 2013-10-04 SM SM201300112T patent/SMT201300112B/xx unknown
-
2015
- 2015-05-07 JP JP2015094972A patent/JP2015164941A/ja active Pending
-
2019
- 2019-08-05 AR ARP190102219A patent/AR114987A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102762577B (zh) | 2015-01-07 |
| AR077483A1 (es) | 2011-08-31 |
| MX2012000680A (es) | 2012-02-28 |
| HK1178159A1 (en) | 2013-09-06 |
| TW201107336A (en) | 2011-03-01 |
| PT2454266E (pt) | 2013-10-10 |
| US20120196876A1 (en) | 2012-08-02 |
| BR112012000750B1 (pt) | 2021-05-25 |
| JP6013911B2 (ja) | 2016-10-25 |
| RU2543721C2 (ru) | 2015-03-10 |
| CA2768210A1 (en) | 2011-01-20 |
| SI2454266T1 (sl) | 2013-10-30 |
| AR114987A2 (es) | 2020-11-11 |
| EP2454266B1 (en) | 2013-07-10 |
| ES2429525T3 (es) | 2013-11-15 |
| DK2454266T3 (da) | 2013-09-08 |
| SMT201300112B (it) | 2013-11-08 |
| JP2012533539A (ja) | 2012-12-27 |
| CN102762577A (zh) | 2012-10-31 |
| JP2015164941A (ja) | 2015-09-17 |
| WO2011008172A1 (en) | 2011-01-20 |
| US9062074B2 (en) | 2015-06-23 |
| CA2768210C (en) | 2017-08-15 |
| RU2012105044A (ru) | 2013-08-20 |
| PL2454266T3 (pl) | 2014-01-31 |
| BR112012000750A8 (pt) | 2018-02-06 |
| TWI537276B (zh) | 2016-06-11 |
| EP2454266A1 (en) | 2012-05-23 |
| BR112012000750A2 (pt) | 2016-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20151324T1 (hr) | Soli nilotiniba i njihovi kristalni oblici | |
| HRP20121028T1 (hr) | Kristalni oblici febuksostata | |
| TWI562991B (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
| IL226392A (en) | An emotion for acquiring physiological signals | |
| HRP20150771T1 (hr) | Spoj za inhibiciju notch signalnog puta | |
| AP2012006189A0 (en) | 2'-fluoro substituted carbanucleoside analogs for antiviral treatment. | |
| ME02805B (me) | Inhibitori cdc7 | |
| IL217566A (en) | Extended detection capability in low contrast for radiographic imaging systems | |
| FR2958291B1 (fr) | Procede de preparation de derives d'amino-benzofurane | |
| ZA200904745B (en) | Spirocyclic tetronic acid derivatives | |
| FR2962731B1 (fr) | Procede de preparation de derives d'amino-benzoyl-benzofurane | |
| PT2744802T (pt) | Compostos para ligação às glicoproteínas iib/iiia específicas de plaquetas e a sua utilização em imagiologia de trombos | |
| SG175066A1 (en) | 6'-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides | |
| FR3002733B1 (fr) | Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2923484B1 (fr) | Procede de preparation de composes morphiniques | |
| EP2220103A4 (en) | NOVEL MANGIFERIN CALCIUM SALTS, PROCESS FOR PREPARING THE SAME AND USE THEREOF | |
| FR2940968B1 (fr) | Procede de preparation de composes fluores olefiniques | |
| FR2947265B1 (fr) | Procede de preparation d'alkylalcanolamines | |
| FR2948360B1 (fr) | Procede de preparation de composes fluores olefiniques | |
| EP2655364A4 (en) | PROCESS FOR THE PREPARATION OF LAPATINIB AND ITS DITOSYLATE SALT | |
| FR2935701B1 (fr) | Procede de preparation de composes fluores olefiniques | |
| IL223752A0 (en) | Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical preparations containing it | |
| FR2946338B1 (fr) | Procede de preparation de composes fluores olefiniques | |
| PL2809329T3 (pl) | Skrobia hydroksyalkilowa w połączeniu z cytostatykiem do leczenia raków poprzez zmniejszenie szybkości wzrostu guza | |
| BR112012000750A2 (pt) | "sal citrato de 9e-15-(2-pirrolidin-1-il-etóxi)-7,12,25-trioxa-19,21,24-triaza-tetraciclo[18.3.1.1(2,5).1(14.18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaeno" |